Efficacy of Triphaladi Avaleha on Beejadushtijanya Pandu (Thalassemia)

| Posted in: Science

Journal name: AYU (Journal of Research in Ayurveda)
Original article title: Efficacy of Triphaladi Avaleha on Beejadushtijanya Pandu (Thalassemia)
AYU is an internationally recognized quarterly journal dedicated to advancing research in Ayurveda. The journal covers a wide range of topics, including clinical and pharmacological research in Ayurveda's eight branches, herbal remedies, phytochemistry, and ethnomedicine.

Original source:

This page is merely a summary which is automatically generated hence you should visit the source to read the original article which includes the author, publication date, notes and references.

Author(s):

Abhishek Y. Patalia
Virendra Kumar Kori
Kalpana S. Patel
S. Rajagopala


AYU (Journal of Research in Ayurveda):

(An International Quarterly Journal of Research in Ayurveda)

Full text available for: Efficacy of Triphaladi Avaleha on Beejadushtijanya Pandu (Thalassemia)

Year: 2014 | Doi: 10.4103/0974-8520.141898

Copyright (license): CC BY-NC-SA 4.0


Download the PDF file of the original publication


Summary of article contents:

Background: Hemoglobinopathies constitute a major public health problem internationally, particularly in the developing world as it has the least resources for coping with the problem. Thalassemia is an inherited single-gene autosomal recessive disorder of the Red Blood Corpuscles (RBCs). Life becomes miserable due to blood transfusion every fortnight, recurrent infections, stunted growth, problems of iron overload, splenectomy, and decreased school performance. Nearly Rs. 1000 Crore is being spent in the treatment of thalassemia per annum.

Other Science Concepts:

[back to top]

Discover the significance of concepts within the article: ‘Efficacy of Triphaladi Avaleha on Beejadushtijanya Pandu (Thalassemia)’. Further sources in the context of Science might help you critically compare this page with similair documents:

Ayurveda, Ayurvedic pharmacopoeia, Blood transfusion, Control group, Rasayana properties, Significant result, Age-group, Clinical Signs and Symptoms, Ethical Clearance, Treatment efficacy, Patient Selection Criteria, Public Health Problem, Dietary advice, Subjective parameter, Objective parameter, Thalassemia major, Hematological investigation, Aamapachana, Maximum improvement, Hemoglobinopathies, Iron overload, Beejadushtijanya Pandu, Chelation therapy, Serum ferritin level, Serum iron, Growth failure, Splenomegaly, Hepatomegaly, Improvement in signs, Significant level, Iron chelation therapy, Social burden, Biological investigation, Clinical parameter.

Like what you read? Consider supporting this website: